← Evidence map

ArticleACS medicinal chemistry letters2014

Discovery of 2-Pyridylpyrimidines as the First Orally Bioavailable GPR39 Agonists.

Stefan Peukert et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

22 papers cite it

2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 25313322